Get startedLog in
    Picture of Contineum Therapeutics logo

    CTNM — Contineum Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Contineum, J&J's depression drug fails to meet mid-stage trial goal

    Picture of Contineum Therapeutics logoContineum Therapeutics
    14/09/2026 21:11
    Contineum, J&J's depression drug fails to meet mid-stage trial goal
    Sept 15 (Reuters) - Contineum Therapeutics CTNM.O said on Monday an experimental depression drug it developed with Johnson & Johnson JNJ.N failed to meet the main goal of a mid-stage study.









     (Reporting by Kamal Choudhury in Bengaluru; Editing by Arun Koyyur)
     ((Kamal.Choudhury@thomsonreuters.com;))

    Recent news on Contineum Therapeutics

    See all news